Contineum Therapeutics
7 clinical trials · Sponsor
◉ Watch Contineum Therapeutics
| Record | Firm | Date |
|---|---|---|
| Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain (NCT06810245) | Contineum Therapeutics | 2025-02-04 |
| Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers (NCT05983939) | Contineum Therapeutics | 2023-06-26 |
| PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers (NCT04941781) | Contineum Therapeutics | 2021-09-01 |
| Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers (NCT04725175) | Contineum Therapeutics | 2021-02-26 |
| Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss (NCT04462198) | Contineum Therapeutics | 2020-10-15 |
Track Contineum Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.